Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation

Developmental Dynamics

Volumn 226, Issue 1, 2003, Pages 24-32

  Zhao, Zhiyong ^a   Rivkees, Scott A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle protein; Cell proliferation; Embryo; Heart; Rho kinase; ROCK; Y27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CELL CYCLE PROTEIN; CYCLIN D3; CYCLIN DEPENDENT KINASE 6; PROTEIN P27; RHO KINASE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART DEVELOPMENT; HEART MUSCLE CELL; HYPOPLASIA; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

AMIDES; ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; G1 PHASE; HEART; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; S PHASE; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

MURINAE;

EID: 0037217745     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.10212     Document Type: Article

References (55)

1. Amano M, Fukata Y, Kalbuchi K. 2000. Regulation and functions of Rho-associated kinase. Exp Cell Res 261:44-51.
2. Aznar S, Lacal JC. 2001. Rho signals to cell growth and apoptosis. Cancer Lett 165:1-10.
3. Bishop AL, Hall A, 2000. Rho GTPases and their effector proteins. Biochem J 348(Pt 2):241-255.
4. Brooks G, Poolman RA, Li JM. 1998. Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors. Cardiovasc Res 39:301-311.
5. Chevrier V, Piel M, Collomb N, Saoudi Y, Frank R, Paintrand M, Narumiya S, Bornens M, Job D. 2002. The Rho-associated protein kinase p160ROCK is required for centrosome positioning. J Cell Biol 157:807-817.
6. Chien KR. 1993. Molecular advances in cardiovascular biology. Science 260:916-917.
7. Coleman ML, Sahal EA, Yeo M, Bosch M, Dewar A, Olson MF. 2001. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3:339-345.
8. Dotto GP. 2000. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta 1471:M43-M56.
9. Fisher SA, Langille BL, Srivastava D. 2000. Apoptosis during cardiovascular development. Circ Res 87:856-864.
10. Fishman MC, Chien KR. 1997. Fashioning the vertebrate heart: earliest embryonic decisions. Development 124:2099-2117.
11. Gaussin V, Van de Putte T, Mishina Y, Hanks MC, Zwljsen A, Huylebroeck D, Behringer RR, Sc̀hneider MD. 2002. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A 99:2878-2883.
12. Harvey RP. 1998. Cardiac looping: An uneasy deal with laterality. Semin Cell Dev Biol 9:101-108.
13. Ishizaki T, Naito M, Fujisawa K, Maekawa M, Watanabe N, Saito Y, Narumiya S, 1997, p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett 404:118-124.
14. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S. 2000. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57:976-983.
15. Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H. 2000. A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J Hepatol 32:762-770.
16. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J Jr, Lefkowitz RJ, Caron MG, Giros B. 1996. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A 93:12974-12979.
17. Johnson DG, Walker CL. 1999. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39:295-312.
18. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T, Otani H, Alba A, Katsuki M. 1997. K-ras is essential for the development of the mouse embryo. Oncogene 15:1151-1159.
19. Koff A, Polyak K. 1995. p27KIP1, an inhibitor of cyclin-dependent kinases. Prog Cell Cycle Res 1:141-147.
20. Kuwahara K, Saito Y, Nakagawa O, Kishimoto I, Harada M, Ogawa E, Miyamoto Y, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Tamura N, Ogawa Y, Nakao K. 1999. The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes - Possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett 452:314-318.
21. Li JM, Brooks G. 1999. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? Eur Heart J 20:406-420.
22. Lu Y, Settleman J. 1999. The role of rho family GTPases in development: Lessons from Drosophila melanogaster. Mol Cell Biol Res Commun 1:87-94.
23. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. 1995. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9:1654-1666.
24. MacLellan WB, Schneider MD. 1999. The cardiac cell cycle. In: Rosenthal N, editor. Heart Development. New York: Academic Press. p 405-427.
25. Montell DJ. 1999. The genetics of cell migration in Drosophila melanogaster and Caenorhabditis elegans development. Development 126:3035-3046.
26. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. 1996. ROCK-I and ROCK-II two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392:189-193.
27. Narumiya S, Ishizaki T, Uehata M. 2000. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 325:273-284.
28. Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, Maroteaux L. 2000. Serotonin 2B receptor is required for heart development, Proc Natl Acad Sci U S A 97:9508-9513.
29. Olson EN, Srivastava D. 1996. Molecular pathways controlling heart development. Science 272:671-676.
30. Pasumarthi KB, Field LJ. 2002. Cardiomyocyte cell cycle regulation. Circ Res 90:1044-1054.
31. Pexieder T. 1975. The embryology of the heart. I. The heart and its systemic tributaries, In: Lilleher CW, editor. Congenital Malformations of the Heart, Embryology, Anatomy, and Operative Considerations. New York: Grune & Stratton. p 38-88.
32. Pruitt K, Der CJ. 2001. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 171:1-10.
33. Ruchhoeft ML, Ohnuma S, McNeill L, Holt CE, Harris WA. 1999. The neuronal architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases in vivo, J Neurosci 19:8454-8463.
34. Rudolph AM. 2000. Myocardial growth before and after birth: Clinical implications. Acta Paediatr 89:129-133.
35. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW Jr, Ross J Jr, Chien KR, Brown JH. 1999. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 103:1627-1634.
36. Sah VP, Seasholtz TM, Sagi SA, Brown JH. 2000. The role of Rho in G protein-coupled receptor signal transduction. Annu Rev Pharmacol Toxicol 40:459-489.
37. Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J. 2001. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 3:346-352
38. Sgambato A, Cittadini A, Faraglia B, Weinstein IB. 2000. Multiple functions of p27(Kip1) and its alterations in tumor cells: A review. J Cell Physiol 183:18-27.
39. Sherr CJ, Roberts JM. 1999, CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
40. Srivastava D. 2001. Genetic assembly of the heart: Implications for congenital heart disease. Annu Rev Physiol 63:451-469.
41. Sturm K, Tam PP. 1993. Isolation and culture of whole postimplantation embryos and germ layer derivatives. Methods Enzymol 225:164-190.
42. Thevananther S, Rivera A, Rivkees SA. 2001. Al adenosine receptor activation inhibits neurite process formation by Rho kinase-mediated pathways. Neuroreport 12:3057-3063.
43. Van Aelst L, D'Souza-Schorey C. 1997. Rho GTPases and signaling networks. Genes Dev 11:2295-2322.
44. van den Hoff MJ, van den Eijnde SM, Viragh S, Moorman AF. 2000. Programmed cell death in the developing heart. Cardiovasc Res 45:603-620.
45. Vuillemin M, Pexieder T. 1989. Normal stages of cardiac organogenesis in the mouse. I. Development of the external shape of the heart. Am J Anat 184:101-113.
46. Webb S, Brown NA, Anderson RH. 1996. The structure of the mouse heart in late fetal stages. Anat Embryol (Berl) 194:37-47.
47. Wei L, Roberts W, Wang L, Yamada M, Zhang S, Zhao Z, Rivkees SA, Schwartz RJ, Imanaka-Yoshida K, 2001, Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development 128:2953-2962.
48. Wei L, Imanaka-Yoshida K, Wang L, Zhan S, Schneider MD, DeMayo FJ, Schwartz RJ. 2002. Inhibition of Rho family GT-Pases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development 129:1705-1714.
49. Wunnenberg-Stapleton K, Blitz IL, Hashimoto C, Cho KW. 1999. Involvement of the small GTPases XRhoA and XRnd1 in cell adhesion and head formation in early Xenopus development. Development 126:5339-5351.
50. Yanagisawa H, Hammer RE, Richardson JA, Williams SC, Clouthler DE, Yanagisawa M. 1998. Role of endothelin-1/endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 102:22-33.
51. Yanazume T, Hasegawa K, Wada H, Morimoto T, Abe M, Kawamura T, Sasayama S. 2002. Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J Biol Chem 277:8618-8625.
52. Zhao Z, Rivkees SA. 2000a. Programmed cell death in the developing heart: Regulation by BMP4 and FGF2. Dev Dyn 217:388-400.
53. Zhao Z, Rivkees SA. 2000b. Tissue-specific expression of GTPas RalA and RalB during embryogenesis and regulation by epithelial-mesenchymal interaction. Mech Dev 97:201-204.
54. Zhao Z, Rivkees SA. 2001. Inhibition of cell proliferation in the embryonic myocardium by A1 adenosine receptor activation, Dev Dyn 221:194-200.
55. Zhao Z, Stock DW, Buchanan AV, Weiss KM. 2000, Expression of Dlx genes during the development of the murine dentition. Dev Genes Evol 210:270-275.